Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26725
Title: | Severe speech impairment is a distinguishing feature of FOXP1-related disorder. | Austin Authors: | Braden, Ruth O;Amor, David J;Fisher, Simon E;Mei, Cristina;Myers, Candace T;Mefford, Heather;Gill, Deepak;Srivastava, Siddharth;Swanson, Lindsay C;Goel, Himanshu;Scheffer, Ingrid E ;Morgan, Angela T | Affiliation: | Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands TY Nelson Department of Neurology, The Children's Hospital at Westmead, Sydney, NSW, Australia Hunter Genetics, John Hunter Hospital, New Lambton Heights, NSW, Australia Orygen and Centre for Youth Mental Health, University of Melbourne, Parkville, VIC, Australia Austin Health Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA Department of Neurology, Boston Children's Hospital, Boston, MA, USA Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands Murdoch Children's Research Institute, Parkville, VIC, Australia Department of Audiology and Speech Pathology and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia The Royal Children's Hospital, Parkville, VIC, Australia Victorian Clinical Genetics Service, Parkville, VIC, Australia |
Issue Date: | 9-Jun-2021 | Date: | 2021-06-09 | Publication information: | Developmental medicine and child neurology 2021; 63(12): 1417-1426 | Abstract: | To delineate the speech and language phenotype of a cohort of individuals with FOXP1-related disorder. We administered a standardized test battery to examine speech and oral motor function, receptive and expressive language, non-verbal cognition, and adaptive behaviour. Clinical history and cognitive assessments were analysed together with speech and language findings. Twenty-nine patients (17 females, 12 males; mean age 9y 6mo; median age 8y [range 2y 7mo-33y]; SD 6y 5mo) with pathogenic FOXP1 variants (14 truncating, three missense, three splice site, one in-frame deletion, eight cytogenic deletions; 28 out of 29 were de novo variants) were studied. All had atypical speech, with 21 being verbal and eight minimally verbal. All verbal patients had dysarthric and apraxic features, with phonological deficits in most (14 out of 16). Language scores were low overall. In the 21 individuals who carried truncating or splice site variants and small deletions, expressive abilities were relatively preserved compared with comprehension. FOXP1-related disorder is characterized by a complex speech and language phenotype with prominent dysarthria, broader motor planning and programming deficits, and linguistic-based phonological errors. Diagnosis of the speech phenotype associated with FOXP1-related dysfunction will inform early targeted therapy. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26725 | DOI: | 10.1111/dmcn.14955 | ORCID: | 0000-0001-7730-1205 0000-0001-7191-8511 0000-0002-6765-8064 0000-0002-2311-2174 0000-0003-1147-7405 |
Journal: | Developmental Medicine and Child Neurology | PubMed URL: | 34109629 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.